BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25630592)

  • 1. Nonconsensual clinical trials: a foreseeable risk of offshoring under global corporatism.
    Spielman B
    J Bioeth Inq; 2015 Mar; 12(1):101-6. PubMed ID: 25630592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. India's growing participation in global clinical trials.
    Gupta YK; Padhy BM
    Trends Pharmacol Sci; 2011 Jun; 32(6):327-9. PubMed ID: 21489644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast, cheap, and out of control? Speculations and ethical concerns in the conduct of outsourced clinical trials in India.
    Kamat VR
    Soc Sci Med; 2014 Mar; 104():48-55. PubMed ID: 24581061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 6. Fair shares: a preliminary framework and case analyzing the ethics of offshoring.
    Gordon C; Zimmerman A
    Sci Eng Ethics; 2010 Jun; 16(2):325-53. PubMed ID: 19629753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands].
    Lehmann B; Mentzer D; Fischer T; Mallinckrodt-Pape K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):410-6. PubMed ID: 19266173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
    Vernillo A
    Am J Bioeth; 2009 Aug; 9(8):45-7. PubMed ID: 19998162
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical issues in research outsourcing.
    Acharya S
    J Dent Educ; 2007 Apr; 71(4):447-8. PubMed ID: 17468303
    [No Abstract]   [Full Text] [Related]  

  • 10. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM; Sheehan M; Clarke S
    Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract]   [Full Text] [Related]  

  • 11. Off-shoring clinical research: exploitation and the reciprocity constraint.
    Mitra AG
    Dev World Bioeth; 2013 Dec; 13(3):111-8. PubMed ID: 22708740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globalized clinical trials and informed consent.
    Annas GJ
    N Engl J Med; 2009 May; 360(20):2050-3. PubMed ID: 19439740
    [No Abstract]   [Full Text] [Related]  

  • 13. Companies facing ethical issue as drugs are tested overseas.
    Kolata G
    N Y Times Web; 2004 Mar; ():A1, A15. PubMed ID: 15022671
    [No Abstract]   [Full Text] [Related]  

  • 14. The perverse consequences of a proposed global tax on research.
    MacDonald C; Walton N
    Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
    [No Abstract]   [Full Text] [Related]  

  • 15. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of researchers loyal to Big Pharma on the ethics and quality of clinical trials in Latin America].
    Ugalde A; Homedes N
    Salud Colect; 2015 Mar; 11(1):67-86. PubMed ID: 25853831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
    Caulfield T
    Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
    [No Abstract]   [Full Text] [Related]  

  • 18. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 20. Globalization of clinical research by the pharmaceutical industry.
    Shah S
    Int J Health Serv; 2003; 33(1):29-36. PubMed ID: 12641261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.